CNS Response, a life science company, has hired Paul Buck as its chief financial officer (CFO). Buck has been working with CNS Response as a financial consultant since December 2008. Reporting directly to chief executive officer (CEO) George Carpenter, Buck will be responsible for all financial aspects of the company including accounting oversight, financial reporting and analysis, and budgeting. He will be the point of contact for all outside accounting and advisory firms.
Prior to joining CNS Response, Buck worked as an independent consultant and has a broad range of experience with a variety of public companies. His projects included forensic accounting, mergers and acquisitions, interim management, and systems implementations. Buck started his career with Touche Ross & Company in Cape Town, South Africa, where he qualified as a chartered accountant. In 1985 he joined the Los Angeles office of Touche Ross & Company, where he was an audit manager. In 1991 he joined the American Red Cross Biomedical Services as CFO of the Southern California Region, and after five years, returned to Deloitte & Touche as a manager in the solutions consulting group. He was recruited back to the American Red Cross Biomedical Services in 1998 and served as the CFO and director of operations for the Southern California Region until 2003.
Buck holds a BSc degree in Chemistry and a Bachelor of Commerce degree, both from the University of Cape Town, South Africa.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.